27446550|t|Heat-shock protein 60 of Porphyromonas gingivalis may induce dysfunction of human umbilical endothelial cells via regulation of endothelial-nitric oxide synthase and vascular endothelial-cadherin
27446550|a|Accumulating evidence has established that periodontitis was an independent risk factor for coronary heart disease (CAD). Porphyromonus gingivalis (P. gingivalis), a major periodontal pathogen, has already been shown to have a significant role in the inflammatory response of CAD in vivo. The aim of the present study was to identify whether P. gingivalis heat-shock protein 60 (HSP60) induced the dysfunction of human umbilical vein endothelial cells (HUVECs) in vitro. HUVECs were stimulated with a range of P. gingivalis HSP60 concentrations (1, 10 and 100 ng/l) at different time-points. The levels of vascular endothelial (VE)-cadherin, endothelial nitric oxide synthase (eNOS) and cysteinyl aspartate-specific protease-3 (caspase-3) were measured using western blot analysis. The apoptotic rate of HUVECs was detected using flow cytometry. P. gingivalis HSP60 at a concentration of 10 ng/l significantly decreased the expression levels of VE-cadherin and eNOS protein at 24 h stimulation, whereas no difference in these proteins was identified following a low dose of P. gingivalis HSP60 (1 ng/l). P. gingivalis HSP60 at 100 ng/l significantly downregulated the expression levels of VE-cadherin and eNOS protein at 12 h in HUVECs. However, the cleavage of caspase-3 showed an opposing change at different concentrations. Consistently, P. gingivalis HSP60 induced apoptosis of HUVECs in a concentration - dependent manner. These results indicated that P. gingivalis HSP60 may induce dysfunction and apoptosis in HUVECs via downregulating the expression levels of VE-cadherin and eNOS, and promoting the cleavage of caspase-3.
27446550	0	21	Heat-shock protein 60	T116,T123	C0109272
27446550	25	49	Porphyromonas gingivalis	T007	C0085478
27446550	61	72	dysfunction	T077	C3887504
27446550	76	109	human umbilical endothelial cells	T025	C3179121
27446550	114	124	regulation	T038	C1327622
27446550	128	161	endothelial-nitric oxide synthase	T116,T126	C0669365
27446550	166	195	vascular endothelial-cadherin	T116,T129	C0300423
27446550	239	252	periodontitis	T047	C0031099
27446550	272	283	risk factor	T033	C0035648
27446550	288	310	coronary heart disease	T047	C0010068
27446550	312	315	CAD	T047	C0010068
27446550	318	342	Porphyromonus gingivalis	T007	C0085478
27446550	344	357	P. gingivalis	T007	C0085478
27446550	368	379	periodontal	T080	C0332275
27446550	380	388	pathogen	T001	C0450254
27446550	447	468	inflammatory response	T046	C1155266
27446550	472	475	CAD	T047	C0010068
27446550	476	483	in vivo	T082	C1515655
27446550	508	513	study	T062	C2603343
27446550	538	551	P. gingivalis	T007	C0085478
27446550	552	573	heat-shock protein 60	T116,T123	C0109272
27446550	575	580	HSP60	T116,T123	C0109272
27446550	594	605	dysfunction	T077	C3887504
27446550	609	647	human umbilical vein endothelial cells	T025	C3179121
27446550	649	655	HUVECs	T025	C3179121
27446550	657	665	in vitro	T080	C1533691
27446550	667	673	HUVECs	T025	C3179121
27446550	679	689	stimulated	T070	C1948023
27446550	706	719	P. gingivalis	T007	C0085478
27446550	720	725	HSP60	T116,T123	C0109272
27446550	726	740	concentrations	T081	C0392762
27446550	775	786	time-points	T079	C2348792
27446550	792	798	levels	T080	C0441889
27446550	802	836	vascular endothelial (VE)-cadherin	T116,T129	C0300423
27446550	838	871	endothelial nitric oxide synthase	T116,T126	C0669365
27446550	873	877	eNOS	T116,T126	C0669365
27446550	883	922	cysteinyl aspartate-specific protease-3	T116,T126	C0291573
27446550	924	933	caspase-3	T116,T126	C0291573
27446550	955	967	western blot	T059	C0949466
27446550	968	976	analysis	T062	C0936012
27446550	982	991	apoptotic	T043	C0162638
27446550	992	996	rate	T081	C1521828
27446550	1000	1006	HUVECs	T025	C3179121
27446550	1026	1040	flow cytometry	T059	C0016263
27446550	1042	1055	P. gingivalis	T007	C0085478
27446550	1056	1061	HSP60	T116,T123	C0109272
27446550	1067	1080	concentration	T081	C0392762
27446550	1120	1130	expression	T045	C1171362
27446550	1131	1137	levels	T080	C0441889
27446550	1141	1152	VE-cadherin	T116,T129	C0300423
27446550	1157	1169	eNOS protein	T116,T126	C0669365
27446550	1176	1177	h	T079	C0439227
27446550	1178	1189	stimulation	T070	C1948023
27446550	1222	1230	proteins	T116,T123	C0033684
27446550	1258	1266	low dose	T081	C0445550
27446550	1270	1283	P. gingivalis	T007	C0085478
27446550	1284	1289	HSP60	T116,T123	C0109272
27446550	1300	1313	P. gingivalis	T007	C0085478
27446550	1314	1319	HSP60	T116,T123	C0109272
27446550	1346	1359	downregulated	T044	C0013081
27446550	1364	1374	expression	T045	C1171362
27446550	1375	1381	levels	T080	C0441889
27446550	1385	1396	VE-cadherin	T116,T129	C0300423
27446550	1401	1413	eNOS protein	T116,T126	C0669365
27446550	1425	1431	HUVECs	T025	C3179121
27446550	1446	1454	cleavage	T067	C0596311
27446550	1458	1467	caspase-3	T116,T126	C0291573
27446550	1507	1521	concentrations	T081	C0392762
27446550	1537	1550	P. gingivalis	T007	C0085478
27446550	1551	1556	HSP60	T116,T123	C0109272
27446550	1565	1574	apoptosis	T043	C0162638
27446550	1578	1584	HUVECs	T025	C3179121
27446550	1590	1603	concentration	T081	C0392762
27446550	1606	1615	dependent	T169	C3244310
27446550	1630	1637	results	T169	C1274040
27446550	1653	1666	P. gingivalis	T007	C0085478
27446550	1667	1672	HSP60	T116,T123	C0109272
27446550	1684	1695	dysfunction	T077	C3887504
27446550	1700	1709	apoptosis	T043	C0162638
27446550	1713	1719	HUVECs	T025	C3179121
27446550	1724	1738	downregulating	T044	C0013081
27446550	1743	1753	expression	T045	C1171362
27446550	1754	1760	levels	T080	C0441889
27446550	1764	1775	VE-cadherin	T116,T129	C0300423
27446550	1780	1784	eNOS	T116,T126	C0669365
27446550	1804	1812	cleavage	T067	C0596311
27446550	1816	1825	caspase-3	T116,T126	C0291573